We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$757M
AUM Growth
+$293M
Cap. Flow
+$210M
Cap. Flow %
27.7%
Top 10 Hldgs %
37.11%
Holding
384
New
211
Increased
9
Reduced
13
Closed
104

Top Buys

Rank Stock Value
1
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$19.6M
2
SPRU icon
Spruce Power Holding Corp
SPRU
+$16.2M
3
SHC icon
Sotera Health
SHC
+$10.7M
4
FHTX icon
Foghorn Therapeutics
FHTX
+$10.7M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$38.1M
2
CZR icon
Caesars Entertainment
CZR
+$18.8M
3
GDRX icon
GoodRx Holdings
GDRX
+$8.9M
4
SNOW icon
Snowflake
SNOW
+$6.28M
5
STEP icon
StepStone Group
STEP
+$5.99M

Sector Composition

Rank Sector Weight
1 Healthcare 30.35%
2 Financials 10.57%
3 Consumer Discretionary 9%
4 Technology 5.91%
5 Industrials 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNOX icon
301
Nano X Imaging
NNOX
$73.8M
– –
-25,000
Closed -$588K
NSA
302
DELISTED
National Storage Affiliates Trust
NSA
– –
-48,500
Closed -$1.59M
NTRA icon
303
Natera
NTRA
$45.9B
– –
-75,000
Closed -$5.42M
NUVB icon
304
Nuvation Bio
NUVB
$2.32B
– –
-79,998
Closed -$896K
ONEW icon
305
OneWater Marine
ONEW
$205M
– –
-85,000
Closed -$1.74M
PENN icon
306
PENN Entertainment
PENN
$2.53B
– –
-62,500
Closed -$4.54M
PRLD icon
307
Prelude Therapeutics
PRLD
$385M
– –
-50,000
Closed -$1.51M
PRPL icon
308
Purple Innovation
PRPL
$39.6M
– –
-600
Closed -$373K
RBOT
309
DELISTED
Vicarious Surgical
RBOT
– –
-6,667
Closed -$1.95M
SHOP icon
310
Shopify
SHOP
$200B
– –
-25,000
Closed -$2.56M
FIRY
311
Firy Inc
FIRY
$164M
– –
-12,500
Closed -$3.04M
SNOW icon
312
Snowflake
SNOW
$116B
– –
-25,000
Closed -$6.28M
STEP icon
313
StepStone Group
STEP
$3.8B
– –
-225,000
Closed -$5.99M
TSHA icon
314
Taysha Gene Therapies
TSHA
$1.83B
– –
-60,000
Closed -$1.34M
TXG icon
315
10x Genomics
TXG
$7.63B
– –
-15,000
Closed -$1.87M
YARW
316
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
– –
-97
Closed -$581K
WVE icon
317
Wave Life Sciences
WVE
$1.2B
– –
-100,000
Closed -$849K
YALA
318
Yalla Group
YALA
$820M
– –
-15,000
Closed -$105K
PTVE
319
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
– –
-200,000
Closed -$2.54M
FRLN
320
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-6,327
Closed -$1.48M
CD
321
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
– –
-80,000
Closed -$1.3M
TMPO
322
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
– –
-199,998
Closed -$1.95M
PIAI.U
323
DELISTED
Prime Impact Acquisition I Units, each consisting of one Class A ordinary share, and one-third of a redeemable Warrant to acquire one Class A ordinary share
PIAI.U
– –
-150,000
Closed -$1.5M
AMRS
324
DELISTED
Amyris Inc.
AMRS
– –
-851,397
Closed -$2.49M
MTEM
325
DELISTED
Molecular Templates, Inc.
MTEM
– –
-33,467
Closed -$5.48M
11 12
13
14 15

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Monashee Investment Management held 384 positions worth $757M, up 63% from $464M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management deployed $210M of net new capital in Q4 2020, opening 211 new positions and adding to 9 existing holdings. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $38.1M trimmed.

  • Monashee Investment Management's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.
  • Monashee Investment Management added most to Quanterix in Q4 2020, an estimated $8.95M increase.
  • Monashee Investment Management's biggest Q4 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $38.1M.
  • Monashee Investment Management fully exited Caesars Entertainment in Q4 2020, selling an estimated $18.8M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $757M portfolio in Q4 2020.
  • Monashee Investment Management opened 211 new positions and closed 104 in Q4 2020.
  • Monashee Investment Management's portfolio value rose 63% quarter-over-quarter to $757M.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.